Genome Editing Shared Resource

Our Mission
The mission of the Genome Editing Shared Resource (GESR) at Rutgers is to provide expertise and assistance in the development and production of genetically modified mouse models that can serve as in vivo models for addressing a wide variety of biological questions.
It is our goal to offer the highest quality services possible at reasonable prices to our scientific community. We apply strict conditions to keep our facility specific pathogen free and to provide a barrier environment for the housing of the transgenic mice.
 
About Us
The Genome Editing Shared Resource at Rutgers Cancer Institute of New Jersey was established in 2016. GESR is now a University core facility led by the Office of Research Advancement (ORAd) under Rutgers' Office of Research and Economic Development. It also functions as an NCI-designated cancer center resource with joint scientific and administrative/fiscal oversight with Rutgers Cancer Institute of New Jersey.
 
The GESR serves as one of America’s largest, most comprehensive university-based research centers. The GESR's main facility is located in New Brunswick with a satellite site in Newark. Its main focus is to provide expertise and technical services required to manipulate the genomes of animals utilizing CRISPR/Cas9-mediated gene editing and, eventually, genome editing of various cell lines including human cells. Standard services such as mouse embryonic stem cell manipulation, in vitro fertilization, embryo or sperm cryopreservation, mouse rederivation, genotyping and breeding services are also available.
 
Contact Information:
Peter Romanienko, PhD
Manager-GESR
CHINJ 4270
89 French St, New Brunswick, NJ 08901
Tel: 732-235-5978
Email: pjr110@cinj.rutgers.edu
 
Ghassan Yehia, PhD
Co-Manager-GESR
CHINJ 4269
89 French St, New Brunswick, NJ 08901
Tel: 732-235-9534
Email: ghassayk@ca.rutgers.edu